Dolby Laboratories (NYSE:DLB – Get Free Report)’s share price hit a new 52-week low during trading on Tuesday after an insider sold shares in the company. The company traded as low as $53.20 and last traded at $53.5250, with a volume of 291085 shares. The stock had previously closed at $54.37.
Specifically, SVP Shriram Revankar sold 3,000 shares of the company’s stock in a transaction that occurred on Friday, May 15th. The stock was sold at an average price of $54.90, for a total value of $164,700.00. Following the sale, the senior vice president owned 80,603 shares of the company’s stock, valued at approximately $4,425,104.70. This represents a 3.59% decrease in their position. The transaction was disclosed in a filing with the Securities & Exchange Commission, which can be accessed through this hyperlink. Also, CFO Robert J. Park sold 4,895 shares of the company’s stock in a transaction that occurred on Tuesday, May 12th. The shares were sold at an average price of $56.68, for a total value of $277,448.60. Following the completion of the sale, the chief financial officer directly owned 81,490 shares in the company, valued at approximately $4,618,853.20. The trade was a 5.67% decrease in their position. The SEC filing for this sale provides additional information.
Analysts Set New Price Targets
A number of equities research analysts recently issued reports on the company. Wall Street Zen lowered Dolby Laboratories from a “buy” rating to a “hold” rating in a research note on Saturday, January 31st. Weiss Ratings reaffirmed a “hold (c-)” rating on shares of Dolby Laboratories in a research note on Friday, March 27th. Barrington Research reiterated an “outperform” rating and issued a $90.00 price target on shares of Dolby Laboratories in a report on Monday, April 27th. Finally, Rosenblatt Securities reiterated a “buy” rating and issued a $85.00 price target on shares of Dolby Laboratories in a report on Friday, January 30th. Three analysts have rated the stock with a Buy rating and two have given a Hold rating to the stock. According to data from MarketBeat.com, the company presently has a consensus rating of “Moderate Buy” and an average price target of $90.75.
Dolby Laboratories Stock Performance
The stock has a market capitalization of $5.11 billion, a price-to-earnings ratio of 21.36 and a beta of 0.86. The firm has a fifty day moving average of $60.22 and a 200-day moving average of $63.42.
Dolby Laboratories (NYSE:DLB – Get Free Report) last announced its quarterly earnings results on Thursday, April 30th. The electronics maker reported $1.37 earnings per share (EPS) for the quarter, beating the consensus estimate of $1.31 by $0.06. The firm had revenue of $395.63 million during the quarter, compared to the consensus estimate of $385.80 million. Dolby Laboratories had a return on equity of 11.47% and a net margin of 17.85%.The firm’s quarterly revenue was up 7.0% compared to the same quarter last year. During the same period in the prior year, the firm earned $1.34 EPS. Dolby Laboratories has set its FY 2026 guidance at 4.300-4.450 EPS and its Q3 2026 guidance at 0.560-0.710 EPS. On average, analysts predict that Dolby Laboratories will post 3.22 EPS for the current year.
Dolby Laboratories Dividend Announcement
The business also recently declared a quarterly dividend, which was paid on Wednesday, May 20th. Stockholders of record on Tuesday, May 12th were given a dividend of $0.36 per share. The ex-dividend date of this dividend was Tuesday, May 12th. This represents a $1.44 annualized dividend and a dividend yield of 2.7%. Dolby Laboratories’s dividend payout ratio (DPR) is presently 56.92%.
Hedge Funds Weigh In On Dolby Laboratories
Large investors have recently modified their holdings of the stock. Ashton Thomas Private Wealth LLC acquired a new position in Dolby Laboratories in the 3rd quarter worth approximately $615,000. JPMorgan Chase & Co. raised its holdings in Dolby Laboratories by 81.3% in the 3rd quarter. JPMorgan Chase & Co. now owns 312,028 shares of the electronics maker’s stock worth $22,582,000 after acquiring an additional 139,900 shares during the period. Alps Advisors Inc. raised its holdings in Dolby Laboratories by 6.7% in the 3rd quarter. Alps Advisors Inc. now owns 281,532 shares of the electronics maker’s stock worth $20,374,000 after acquiring an additional 17,592 shares during the period. Teacher Retirement System of Texas increased its holdings in shares of Dolby Laboratories by 19.1% during the 4th quarter. Teacher Retirement System of Texas now owns 115,772 shares of the electronics maker’s stock worth $7,435,000 after purchasing an additional 18,579 shares during the period. Finally, Clifford Capital Partners LLC increased its holdings in shares of Dolby Laboratories by 15.2% during the 3rd quarter. Clifford Capital Partners LLC now owns 304,311 shares of the electronics maker’s stock worth $22,023,000 after purchasing an additional 40,252 shares during the period. Institutional investors own 58.56% of the company’s stock.
About Dolby Laboratories
Dolby Laboratories, Inc is a global leader in audio and imaging technologies, specializing in the development, licensing and deployment of solutions that enhance entertainment and communications experiences. The company’s core business revolves around creating advanced audio codecs, noise reduction systems and spatial sound technologies for a wide range of applications, including cinema, broadcast, gaming, streaming and personal devices. Dolby’s licensing model enables consumer electronics manufacturers, content creators and service providers to integrate its technologies into products such as televisions, smartphones, home theater systems and set-top boxes.
Among its flagship innovations are Dolby Atmos, an immersive audio format that delivers three-dimensional soundscapes for theaters and home systems; Dolby Digital and Dolby Digital Plus, widely adopted audio compression formats for broadcast and streaming; and Dolby Vision, a high-dynamic-range imaging technology that expands color, contrast and brightness in displays.
Featured Stories
- Five stocks we like better than Dolby Laboratories
- Meta Platforms 10% Layoff Raises a Bigger Question About AI Spending
- As Small-Cap Outperformance Continues, These 2 ETFs Provide Exposure
- Silicon Shake-Up: The AI Trade Is Moving Beyond NVIDIA
- The Silver Lining of Last Week’s Hims & Hers Earnings Miss
Receive News & Ratings for Dolby Laboratories Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Dolby Laboratories and related companies with MarketBeat.com's FREE daily email newsletter.
